kumar, Panigrahi Hemanta; Kumar, Rana Rakesh; Rao, M. M.
November 2012
International Journal of Research in Ayurveda & Pharmacy;Nov/Dec2012, Vol. 3 Issue 5, p868
Academic Journal
This interventional, quasi-experimental study (pre-post test design) was conducted at Ayurveda Central Research Institute, New Delhi to study the efficacy of Leech Therapy along with some Ayurvedic medicine in vitiligo. Patients were selected by non-probability purposive sampling method after obtaining an informed consent. Twenty patients suffering from vitiligo (12 male and 08 female), aged more than 15 years and involving less than 25% of body surface area were enrolled. All the patients were kept in a single group. All the patients were called to OPD for Leech application once in a week. The patients were followed up weekly for first month and later on fortnightly for five months to monitor the improvement and adverse effects. The mean re-pigmentation achieved was 60 % (VASI score of 3.69), while the arrest of progression (stationary) was noted in 35 % of patients. In 5% of patient it was spreading. We recommend that leech therapy along with internal administration of Ayurvedic medicine is effective in the treatment of Vitiligo.


Related Articles

  • Bloodletting - An Ayurvedic perspective. Sathish, H. S.; Vaghela, D. B. // Journal of Postgraduate Medicine;Jul-Sep2011, Vol. 57 Issue 3, p253 

    A letter to the editor is presented in response to the article "Clinical uses of the medicinal leech: A practical review," which discusses the process of Raktamoshana or in other words, bloodletting.

  • A CLINICAL STUDY TO COMPARE THE ROLE OF JALADHARA AND SANKHAPUSPI RASAYAN IN THE MANAGEMENT OF CHITTODVEGA (ANXIETY DISORDERS). Dass, Ranjip Kumar // International Journal of Research in Ayurveda & Pharmacy;Nov/Dec2012, Vol. 3 Issue 5, p872 

    Chittodvega is a Manasa Vikara described by Charak. It has been considered as a perfect word for highlighting the status of anxiety, which is produced due to vitiation of Raja and Tama. In addition Prana, Udana, Vyana Vayu; Sadhaka Pitta; and Tarpaka Kapha are also provocated factors in it. On...

  • FDA: Trial Jitters? Forgo PFS, Use Overall Survival Endpoint. Young, Donna // BioWorld Today;10/9/2009, Vol. 20 Issue 195, p2 

    The article reports on the increased number of applications to the U.S. Food and Drug Administration (FDA) based on progression-free survival (PFS) data. FDA Director Richard Pazdur reminded drugmakers about the perils and problems associated with PFS endpoints, including drug indications,...

  • Jalaukavacharan (Leech Application): Para-Surgical Approach to Shlipada (Fileriasis): A Pilot Study. Bhuyan, Chatrubhuja; Dudhamal, T. S.; Gupta, S. K. // Indian Journal of Ancient Medicine & Yoga;Jul-Sep2012, Vol. 5 Issue 3, p131 

    The disease Shlipada is described in the Ancient medical science i.e. Ayurveda which resembles to fileriasis. The prevalence of this disease is more in coastal area and is still challenge to the medical field due to its poor prognosis. The disease is manifested due to the infestation of organism...

  • ANTI INFLAMMATORY EFFECT OF LEECH THERAPY IN THE PATIENTS OF PSORIASIS (EK KUSTHA). Singh, Akhilesh Kumar // Journal of Pharmaceutical & Scientific Innovation;Jan/Feb2012, Vol. 1 Issue 1, p71 

    Ek kustha is a type of kshudra kustha described in different Ayurvedic classics. It is a vata-kaphaj disorder. The clinical symptom of Ek kustha described in Ayurveda resembles with the clinical symptom of Psoriasis. The clinical feature of Ek kustha described by Kashyap represents remission,...

  • The administration of pitavastatin augments creatinine clearance associated with reduction in oxidative stress parameters: acute and early effects. Kakuda, Hirokazu; Kanasaki, Keizo; Koya, Daisuke; Takekoshi, Noboru // Clinical & Experimental Nephrology;Apr2013, Vol. 17 Issue 2, p240 

    Background: Chronic kidney disease (CKD) is a serious health problem worldwide. Therapies that can halt the progression of CKD are limited, and the identification of new strategies for CKD treatment is therefore important. Pitavastatin, one of the newest statins introduced to the market, has...

  • A Focus on Medication Safety in the Intensive Care Unit. Patel, Gourang // Current Drug Safety;Jan2010, Vol. 5 Issue 1, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics related to medication safety.

  • Beyond Bloodletting: FDA Gives Leeches a Medical Makeover. Rados, Carol // FDA Consumer;Sep2004, Vol. 38 Issue 5, p9 

    Reports on the approval given by the U.S. Food and Drug Administration for the use of leeches as medical devices. Benefit of using leeches when regrafting amputated appendages; Data considered by the agency in reviewing the marketing application for leeches; Proper breeding of the leeches used...

  • IMPORTED FROM FRANCE: WINE, TRUFFLES AND NOW- LEECHES.  // Time;7/12/2004, Vol. 164 Issue 2, p88 

    Reports that the French company Ricarimpex SAS has received the United States Food and Drug Administration's approval to market leeches for medicinal purposes.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics